🔗 Share this article

The top legal official in Texas Paxton is filing a lawsuit against the producers of acetaminophen, asserting the corporations concealed alleged dangers that the pain reliever presented to pediatric cognitive development.

The court filing follows a month after Former President Trump advocated an unverified association between consuming acetaminophen - alternatively called paracetamol - during pregnancy and autism in offspring.

The attorney general is filing suit against the pharmaceutical giant, which previously sold the drug, the only pain reliever suggested for women during pregnancy, and Kenvue, which currently produces it.

In a official comment, he said they "betrayed America by gaining financially from suffering and pushing pills regardless of the risks."

The manufacturer states there is no credible evidence linking acetaminophen to autism spectrum disorder.

"These companies lied for decades, knowingly endangering millions to increase profits," the attorney general, a Republican, stated.

The company stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the welfare of American women and children."

On its website, the company also mentioned it had "regularly reviewed the relevant science and there is lacking reliable evidence that demonstrates a proven link between consuming paracetamol and autism spectrum disorder."

Groups acting on behalf of doctors and healthcare providers agree.

ACOG has said acetaminophen - the main ingredient in Tylenol - is one of the few options for expectant mothers to treat discomfort and fever, which can pose serious health risks if ignored.

"In over twenty years of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of acetaminophen in any trimester of gestation leads to brain development issues in young ones," the association commented.

This legal action references latest statements from the previous government in claiming the medication is potentially dangerous.

Recently, Trump raised alarms from medical authorities when he told expectant mothers to "fight like hell" not to consume Tylenol when unwell.

The FDA then issued a notice that physicians should think about restricting the usage of Tylenol, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would determine the origin of autism in a limited time.

But authorities warned that identifying a sole reason of autism spectrum disorder - considered by experts to be the consequence of a complex mix of genetic and surrounding conditions - would be difficult.

Autism is a type of lifelong neurodivergence and disability that impacts how people experience and engage with the surroundings, and is recognized using physician assessments.

In his legal document, Paxton - aligned with the former president who is seeking the Senate - asserts the manufacturer and Johnson & Johnson "willfully ignored and tried to quiet the science" around paracetamol and autism.

This legal action seeks to make the corporations "remove any commercial messaging" that claims Tylenol is secure for expectant mothers.

The court case mirrors the grievances of a assembly of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the manufacturers of acetaminophen in recently.

The court rejected the lawsuit, stating studies from the plaintiffs' authorities was not conclusive.